Oracle's Larry Ellison says AI-driven cancer vaccine could be coming soon as Donald Trump announces a $500 billion investment.

Oracle Chairman Larry Ellison recently discussed the transformative potential of artificial intelligence (AI) in healthcare during a meeting at the White House, which also featured SoftBank CEO Masayoshi Son and OpenAI CEO Sam Altman. According to Ellison, AI could revolutionize cancer detection, treatment, and vaccine development, offering groundbreaking capabilities.

Ellison explained that tiny tumour fragments can circulate in a person’s blood, allowing for the possibility of early cancer detection through blood tests. AI could be used to analyze these tests and identify cancer early on. Once the cancerous tumour is gene-sequenced, an individualized vaccine could be created for each patient. Using AI, the mRNA vaccine could be produced robotically in just 48 hours, offering rapid and personalized treatment.

Ellison emphasized the incredible potential of AI in advancing cancer care, envisioning a future where early detection, personalized cancer vaccines, and their rapid production could become a reality within just two days. This vision represents the immense promise of AI for the future of medicine.

In addition to these advancements, Oracle, SoftBank, and OpenAI have announced a joint venture named Stargate. The venture aims to develop data centres and generate over 100,000 jobs in the United States. The companies and other investors behind Stargate have committed to investing $100 billion in the next four years to support the project.

Ellison further revealed that construction of the first data centres for Stargate is already underway in Texas. The project plans to build 20 data centres, each spanning half a million square feet. These facilities could enable AI-powered applications that analyze electronic health records and assist doctors in providing better patient care.